✦ LIBER ✦

Inactivation of the cyclin-dependent kinase inhibitor 2A (CDKN2A) gene in squamous cell carcinoma of the larynx

✍ Scribed by Robert Smigiel; Maria Sasiadek; Tomasz Krecicki; David Ramsey; Jozef Jagielski; Nikolaus Blin

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 226 KB
Volume: 39
Category: Article
ISSN: 0899-1987
DOI: 10.1002/mc.20007

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Defects in the system controlling the cell cycle can lead an increased proliferation of cancer cells. The aim of our study was to analyze the relationship between genetic changes leading to inactivation of the CDKN2A gene and subsequent alteration of protein expression in squamous cell cancer of the larynx (SCCL) in connection with the clinical and histopathological course of the disease. Analysis was carried out on DNA isolated from the blood and primary larynx cancer cells of 62 patients. To investigate loss of heterozygosity (LOH), PCR fragment analysis was applied. The size and quantity of fluorescent PCR products were evaluated in an automated sequencer. Specific chemical methylation with sodium bisulfite in a sequential PCR reaction (MSP) was applied to analyze promoter methylation. Cancer tissue sections served to determine the level of protein expression with immunohistochemical (IHC) staining and commercial antibodies. LOH at the CDKN2A locus was observed in 55.35% of the informative cases. Aberrant methylation was found in 37.5% and a decreased level of protein expression observed in 45% of all informative cases. Whenever P16 expression was decreased, LOH and promoter hypermethylation at CDKN2A were observed with a frequency of 73.33% and 80.95%, respectively (Fisher's test, P < 0.005). Sixty‐nine percent of G3 tumors had at least one genetic alteration at CDKN2A, compared with 40.9% of G1 cancers. The results indicate that CDKN2A inactivation played a significant role in the development of squamous cell carcinoma of the larynx. © 2004 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Analysis of cyclin-dependent kinase inhi

Analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in childhood rhabdomyosarcoma

✍ Achille Iolascon; Maria Felicia Faienza; Brigida Coppola; Angelo Rosolen; Giusep 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

p I 6"K4A, p I 5"K4B, and p i 8 proteins are highly specific inhibitors of cyclin-dependent serindthreonine kinase (CDK) activities required for G IS transition in the eukaryotic cell division cycle. Mutations, mainly homozygous deletions, of the CDKN2A (p16"K4A/MTSI) gene have been recently found i

The gene for the cyclin-dependent-kinase

The gene for the cyclin-dependent-kinase-4 inhibitor, CDKN2A, is preferentially deleted in malignant mesothelioma

✍ Jan-Bas Prins; Kathy A. Williamson; Marga M. K. Kamp; Ed J. Van Hezik; Theo H. V 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 71 KB

Cytogenetic deletions of the short arm of chromosome 9, 9p, have been detected in cell lines of malignant mesothelioma as well as in tumor material. Many tumor types carry deletions of chromosome 9 or more specifically of 9p21. The tumor-suppressor genes, CDKN2A and CDKN2B, each of which encodes a s

DNA studies underestimate the major role

DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas

✍ Chu Lee Wu; Luca Roz; Susan McKown; Philip Sloan; Andrew P. Read; Susan Holland; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

Loss of CDKN2A expression was demonstrated by immunohistochemistry in 87% of oral and oropharyngeal squamous cell carcinoma (OSCC) primary tumor samples. By contrast, DNA studies showed a much lower frequency of loss of the CDKN2A gene. Point mutations and promoter methylation of CDKN2A were seen in

Overexpression of Bcl-2 in squamous cell

Overexpression of Bcl-2 in squamous cell carcinoma of the larynx: A marker of radioresistance

✍ Luke T. Condon; James N.E. Ashman; Stephen R. Ell; Nicholas D. Stafford; John Gr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 68 KB 👁 1 views

## Abstract Squamous cell carcinoma of the larynx can be treated using radiotherapy or surgery, either alone or in combination. Radiotherapy is preferred for early‐stage tumours, as it spares the larynx and therefore preserves speech and swallowing. Unfortunately, approximately 15% of tumours treat

Reduced expression of cyclin-dependent k

Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is an indicator of malignant behavior in oral squamous cell carcinoma

✍ Yasusei Kudo; Takashi Takata; Wataru Yasui; Ikuko Ogawa; Mutsumi Miyauchi; Toshi 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views

Reduced expression of the cyclin-dependent kinase inhibitor p27 Kip1 has been reported to correlate with poor survival in cohorts of breast and colorectal carcinoma patients. Posttranslational ubiquitin-mediated proteasomal proteolysis is related to p27 Kip1 protein levels. However, to the authors'

Genomic DNA and messenger rna expression

Genomic DNA and messenger rna expression alterations of the CDKN2B and CDKN2 genes in esophageal squamous carcinoma cell lines

✍ Xiaoling Zhou; Hiroyuki Suzuki; Yutaka Shimada; Masayuki Imamura; Jing Yin; Hai- 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB

## Abstract The genes __CDKN2B (MTS2__) and __CDKN2 (MTSI)__ encoding the proteins p15 and p16 are both located on chromosomal band 9p21, a locus at which frequent homozygous and heterozygous deletions occur in many primary human tumors, including esophageal carcinoma. __CDKN2__ and __CDKN2B__ belo